Mostra 1 - 8 risultati di 8 ricerca 'Laina D Mercer', tempo di risposta: 0,04s
Raffina i risultati
-
1
-
2
The risk of type 2 oral polio vaccine use in post-cessation outbreak response di Kevin A. McCarthy, Guillaume Chabot-Couture, Michael Famulare, Hil M. Lyons, Laina D. Mercer
Pubblicazione 2017-10-01
Articolo -
3
Is the positive association between middle-income and rich household wealth and adult sub-Saharan African women’s overweight status modified by the level of education attainment? A... di Ifeoma D. Ozodiegwu, Henry V. Doctor, Megan Quinn, Laina D. Mercer, Ogbebor Enaholo Omoike, Hadii M. Mamudu
Pubblicazione 2020-06-01
Articolo -
4
Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Mal... di Michael B Arndt, Jason L Cantera, Laina D Mercer, Michael Kalnoky, Heather N White, Gregory Bizilj, David S Boyle, Eugenio L de Hostos, Robert K M Choy
Pubblicazione 2020-09-01
Articolo -
5
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlle... di Rahsan Erdem, Gwen Ambler, Mohamed Al-Ibrahim, Katarzyna Fraczek, Steven D Dong, Christopher Gast, Laina D Mercer, Michael Raine, Sharon M Tennant, Wilbur H Chen, Eugenio L de Hostos, Robert K M Choy
Pubblicazione 2021-11-01
Articolo -
6
Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan di Laina D. Mercer, Rana M. Safdar, Jamal Ahmed, Abdirahman Mahamud, M. Muzaffar Khan, Sue Gerber, Aiden O’Leary, Mike Ryan, Frank Salet, Steve J. Kroiss, Hil Lyons, Alexander Upfill-Brown, Guillaume Chabot-Couture
Pubblicazione 2017-10-01
Articolo -
7
Assessing the sensitivity of the polio environmental surveillance system. di Steve J Kroiss, Maiwand Ahmadzai, Jamal Ahmed, Muhammad Masroor Alam, Guillaume Chabot-Couture, Michael Famulare, Abdirahman Mahamud, Kevin A McCarthy, Laina D Mercer, Salman Muhammad, Rana M Safdar, Salmaan Sharif, Shahzad Shaukat, Hemant Shukla, Hil Lyons
Pubblicazione 2018-01-01
Articolo -
8
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 tr... di Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn, Piengthong Narakorn, Somchaiya Surichan, Sumalee Prangpratanporn, Suttida Puksuriwong, Steven Lamola, Laina D. Mercer, Rama Raghunandan, Weina Sun, Yonghong Liu, Juan Manuel Carreño, Rami Scharf, Weerapong Phumratanaprapin, Fatima Amanat, Luc Gagnon, Ching-Lin Hsieh, Ruangchai Kaweepornpoj, Sarwat Khan, Manjari Lal, Stephen McCroskery, Jason McLellan, Ignacio Mena, Marcia Meseck, Benjaluck Phonrat, Yupa Sabmee, Ratsamikorn Singchareon, Stefan Slamanig, Nava Suthepakul, Johnstone Tcheou, Narumon Thantamnu, Sompone Theerasurakarn, Steven Tran, Thanakrit Vilasmongkolchai, Jessica A White, Nina Bhardwaj, Adolfo Garcia-Sastre, Peter Palese, Florian Krammer, Kittisak Poopipatpol, Ponthip Wirachwong, Richard Hjorth, Bruce L Innis
Pubblicazione 2022-03-01
Articolo